-

Citigroup Announces Full Redemption of Series U Preferred Stock

NEW YORK--(BUSINESS WIRE)--Citigroup Inc. is redeeming, in whole, all $1.5 billion aggregate liquidation preference of Series U Depositary Shares representing interests in its 5.000% Fixed Rate / Floating Rate Noncumulative Preferred Stock, Series U (the “Preferred Stock”).

The redemption date is September 12, 2024 for the Preferred Stock and related Depositary Shares (the “Redemption Date”). The cash redemption price, payable on the Redemption Date for each Depositary Share, will equal $1,000. Holders of record on August 30, 2024, will receive the previously declared regular semi-annual dividend of $25.00 per Depositary Share payable on the Redemption Date.

The redemption announced today is consistent with Citigroup’s liability management strategy and reflects its ongoing efforts to enhance the efficiency of its funding and capital structure. Citigroup’s redemptions are based on several factors, including without limitation, the economic value, regulatory changes, potential impact on Citigroup's net interest margin and borrowing costs, the overall remaining tenor of Citigroup's debt portfolio, capital impact, as well as overall market conditions.

Beginning on the Redemption Date, the Depositary Shares representing the redeemed Preferred Stock will no longer be outstanding and dividends will no longer accrue on such securities.

Computershare Trust Company, N.A. (“Computershare”) is the paying agent for the Depositary Shares. The paying agent’s address is Computershare Trust Company, Attn: Corporate Actions, 150 Royall Street, Suite 101, Canton, MA 02021. Questions relating to the notice of redemption and related materials should be directed to Computershare via telephone at 1-888-250-3985.

For further information on the Preferred Stock and the related Depositary Shares, please see the prospectus at the following web address: https://www.citigroup.com/rcs/citigpa/akpublic/storage/public/CitiSept091219PreferredStockSeriesU.pdf

About Citi

Citi is a preeminent banking partner for institutions with cross-border needs, a global leader in wealth management and a valued personal bank in its home market of the United States. Citi does business in nearly 180 countries and jurisdictions, providing corporations, governments, investors, institutions and individuals with a broad range of financial products and services.

Additional information may be found at www.citigroup.com | X: @Citi | LinkedIn: www.linkedin.com/company/citi | YouTube: www.youtube.com/citi | Facebook: www.facebook.com/citi

Contacts

Media Contact:
Danielle Romero Apsilos
212 816 2264
danielle.romeroapsilos@citi.com

Fixed Income Investor Contact:
Peter Demoise
212 559 2718
peter.demoise@citi.com

Citigroup Inc.

NYSE:C

Release Versions

Contacts

Media Contact:
Danielle Romero Apsilos
212 816 2264
danielle.romeroapsilos@citi.com

Fixed Income Investor Contact:
Peter Demoise
212 559 2718
peter.demoise@citi.com

More News From Citigroup Inc.

The Siam Commercial Bank Collaborates With Citi to Pioneer 24/7 USD Clearing for Near Real-Time Cross-Border Payments With Citi Token Services

NEW YORK--(BUSINESS WIRE)--The Siam Commercial Bank (SCB) and Citi announce SCB as the first financial institution client globally to go live with Citi’s newly integrated 24/7 USD Clearing and Citi Token Services solution. With this, Citi is enabling near real-time, round-the-clock, cross-border USD payments for its corporate and institutional clients. This collaboration is a demonstration of both institutions' commitment to digital innovation as a driver of commercial growth. For The Siam Comm...

Citi Appointed as Depositary Bank for Vicore Pharma Holding AB’s ADR Program

LONDON--(BUSINESS WIRE)--Citi Issuer Services, acting through Citibank N.A., has been appointed by Vicore Pharma Holding AB (“Vicore Pharma”), a clinical-stage biopharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential in respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF), to act as Depositary Bank for its sponsored Level 2 American Depositary Receipt (“ADR”) program. Vicore Pharma’s ADRs trade on the Nasdaq Capital M...

Citibank Announces $1.5 Billion Redemption of 4.929% Notes Due 2026 and $1 Billion Redemption of Floating Rate Notes Due 2026

NEW YORK--(BUSINESS WIRE)--Citibank, N.A. is announcing the redemption, in whole, constituting $1,500,000,000 of its 4.929% Notes due 2026 (the “fixed rate notes”) (ISIN: US17325FBJ66) and $1,000,000,000 of its Floating Rate Notes due 2026 (the “floating rate notes” and together with the fixed rate notes, the “notes”) (ISIN: US17325FBH01). The redemption date for the notes is July 6, 2026 (the “redemption date”). The cash redemption price for the notes payable on the redemption date will equal...
Back to Newsroom